pulm Flashcards
S and S of asthma
respiratory distress at rest diaphoresis RR over 28 pulse >110 pulsus paradoxus >12- unique feature of asthma hyperressonance
astuma ominous signs
fatigue paradoxical chest or ab movment absent breath sounds can be recumbant cyanosis
asthma labs
slight wbc elevation withh eosinophilla
initially resp acidosis with mild hypoxemia on ABG
HYPERCAPNEA IS AN OMINOUS FINDING
A PC02 >45MMMHG INDICATES AN EMERGENCY
A NORMAL PCO2 (35-45) IS A VERY SICK PATIENT
chest x-ray is only useful to rule out other conditions
would show hyperinflation
asthma PFT
hospitilazation with initial FEV-1 is <30% predicted or dose not increase by at least 40% after one hour of vigorous therapy
hospialization is reccomended if peak flow is <60L/min ainitiallly and doesn to improve to >50% predicted after 1 hour of treatment.
general improvment in FVC or FEV1 of 15% or FEF 25-75 of 25% after inhailed bronchodialator
outpatient management of asthma -
short acting B2 adrenergic agonist (albuterol, for symptom releife before exercise
Short acting B2 adrenergic agonist
albuteral or proventil step one
step 2 daily maintenance with inhaled corticosteroids
budesonide (pulmicort) triacinolone (amacort
side effects of step 2 inhaled corticosteroids
(rinse mouth) candidal infection of oropharynx, dry mouth, sore throat,
step 3 asthma
short acting b2 adrenergic agonist - albuterol, proventil for symptom breakthrough
if symptoms persist beyond step 3 then
increase corticosteroid dose or add LONG acting b2 adrenergic agonist (salmeterol (servent) or ipratropium bro- arovent -good for lots of secretions
useful for chronic asthma
antileukotryines- singulair
Inpatient managment of asthma
02 at 2-3 L
mild to mod- abg not necessary, if sa02 is over 90%
abg for less than 90%
hydration oral or IV
inhaled sympathomimetics
alupent (0.3cc in 5% soutions) in 2.2 ml nss q 30-60mins
proventil,
proventil or ventolin inhaled
corticosteroids
methlprednisolone 60-125mg IV x1 and then 20mg q 4or 6 untill attack is broken
can use parenteral sympathomimetics in pts who cant do po
can also use anticholonergic (atrovent
black box on leukotryins and LABA
dont take in acute attack singular or salmeterol
Status asthmaticus def
severe acute asthma presenting in an unremitting, poorly responsive, life thereatening manner,
status asthmaticus management
02
D51/2 ns
inhaled and pareneral sympathomimetics- alupent or proventil or ventolin
methylpred-60-125IV or hydroortisone 300iv now
consider atrovent- 2-6puffs q4-6 anticholinergic
continous pulse ox
freq ABG
tube if necessary
Chronic bronchitis
characterized by excessive bronchial mucous and is manifested by productive cough for 3months or more in at least tow consecutive years
Emphysema
abnormal, permanent enlargement of the alveoli
emphysema symptoms
progressive constant dyspnea onset of symptms after 50 min clear sputum thin increase in chest AP diameter hyperressonant precussion normal hematocrit increased total lung capacity
chronic bronchitis symptoms
intermittant mild to mod dypsnea symptoms onset after age 35 COPIUS PURULENT SPUTEM PRODUCTION stocky body habitus normal chest AP diameter bulla blebs on cxr hyperinfation on cxr HEMATOCRIT INCREASED hypercapnea hypoxia on ABG
COPD fev and volume stuff
FEV is down but TLC< FRC and RV may be up
COPD management outpatint
stop smoking
aovind irritants
postural drainage
INHALED IPRATROPIUM BROMIDE (ATROVENT) OR SYMPATHOMIMETICS (PROVENTIL, VENTOLIN)MAINSTAY OF THERAPY
COPD inpatient
02 at 1-2L per min or 24-28% on venti mask
pharmacologic progression as with asthma
purluent sputem gets abx for 7-10 days
copd inpaitient ABX
ampicilin or amox- 500mg four times per day
doxy 100mg bid or
bactrim DS 1 tab BID
TB def
systemic disease caused by M Tuberculosis. Pulm disease, is the most common clinical presentation, othe sites of involvment include lymphatics, denitourinary, bone, meningies, perotoneum and heart
TB most at risk
crowded living conditions, the institutionalized, HIV +, those with DM, chronic renal players, malignancy, malnutrition and the immunosuppressed.